Clinical Trial Update: Dupilumab Efficacy on Bronchial Inflammation, Small Airways Disfunction and Mucous Secretion

View source ↗

Summary

This clinical trial update reports on dupilumab's efficacy in treating asthma-related bronchial inflammation, small airways dysfunction, and mucus secretion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Dupilumab (dupilumab)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Asthma; Eosinophilic | Status: UNKNOWN